Comparison the effectiveness of damped sine wave monophasic and rectilinear biphasic shocks in patients with persistent atrial fibrillation;Porovnanie účinnosti monofázickej a bifázickej elektrickej kardioverzie u pacientov s perzistujúcou fibriláciou predsiení

Kardiologia

Volumn 15, Issue 5, 2006, Pages 265-278

  Kmec, Ján ^a  

^a Kliniky kardiológie FNsP J A Reimana v Pre ove   (Slovakia)

Author keywords

Atrial fibrillation; Biphasic electrical shock; Electrical cardioversion; Monophasic electric shock; Sinus rhythm

Indexed keywords

AMIODARONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPAFENONE; SOTALOL; VERAPAMIL;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BODY MASS; CARDIOMYOPATHY; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART SINOATRIAL BLOCK; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE SIZE; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTENSION; HYPOTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SINUS BRADYCARDIA; SINUS RHYTHM; SUPRAVENTRICULAR PREMATURE BEAT; THROMBOEMBOLISM; WAVEFORM;

EID: 33749333800     PISSN: 12100048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lip GYH. History of atrial fibrillation. In: Atrial fibrillation in clinical practice. London: Martin Dunitz Ltd. 2001;3-9.
2. Gersh BJ, Tsang TSM, Barnes ME, et al. The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors. Eur Heart J 2005;(Suppl C):C5-C11.
3. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for Management of Patients With Atrial Fibrillation) Developed in Collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-1923.
4. Lip GYH. Persistent atrial fibrillation and cardioversion In: Atrial fibrillation in clinical practice. London: Martin Dunitz Ltd. 2001;151-182.
5. Vardas PE, Kanoupakis EM. Electrical cardioversion for atrial fibrillation: optimising methods and patient selection. Cardiology International 2002. Atrial fibrillation special issue - summer 2002:S9-S11.
6. Richard Ph, Yaici K, Rinaldi JP, et al. Cardioversion of atrial fibrillation: how and when? Eur Heart J 2003;(Suppl. H):H40-H44.
7. Reddy RK, Gleva MJ, Gliner BE, et al. Biphasic transthoracic defibrillation causes fewer ECG ST-segment changes after shock. Annals of Emergency Medicine 1997;30:127-134.
8. Mittal S, Ayati Sh, Stein KM, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000;101:1282-1287.
9. Walsh SJ, Glover BM, Adgey AAJ. The role of biphasic shocks for transthoracic cardioversion of atrial fibrillation. Indian Pacing and Electrophysiology Journal 2005;5:289-295.
10. Siaplaouras S, Buob A, Rotter C, et al. Impact of biphasic electrical cardioversion of atrial fibrillation on early recurrent atrial fibrillation and shock efficacy. J Cardiovasc Electrophysiol 2004;15:895-897.
11. Page RL, Kerber RE, Russell JK, et al. forthe BiCard Investigators: Biphasic versus monophasic shock waveform for conversion of atrial fibrillation. J Am Coll Cardiol 2002;39:1956-1963.
12. Schoften M, Szili-TorokT, Klootwijk P, Jordaens L. Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation. Heart 2003;89:1032-1034.
13. Marinsek K, Larkin GL, Zohar P, et al. Efficacy and impact of monophasic versus biphasic countershocks for transthoracic cardioversion of persistent atrial fibrillation. Am J Cardiol 2003;92:988-991.
14. Gurevitz OT, Ammash NM, Malouf JF, et al. Comparative efficacy of monophasic and biphasic waveform for transthoracic cardioversion of atrial fibrillation and atrial flutter. Am Hear J 2005;149:316-321.
15. Kirchhof P, Monnig G, Wasmer K, et al. A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior positions. Eur Heart J 2005;26:1298-1302.
16. Ricard P, Levy S, Boccara G, et al. External cardioversion of atrial fibrillation: comparison of biphasic versus monophasic waveforms shocks. Europace 2001;3:96-99.
17. Elhendy A, Gentile F, Khandheria BK, et al. Predictors of unsuccessful electrical cardioversion in atrial fibrillation. Am J Cardiol 2002;89:83-86.
18. Levy S, Breithard G, Campbell WF, et al. Atrial fibrillation: Current knowledge and recommendations for management. Eur Heart J 1998;19:1294-1320.
19. Oral H, Souza JJ, Michaud GF, et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pre-treatment. N Engl J Med 1999;340:1849-1854.
20. Gorecki A, Stec S, Kulakovski P, et al. Initial energy needed for rectilinear biphasic cardioversion of persistent fibrillation. Europace 2005 (Abstract):539.
21. Marcus GM, Sung RJ. Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting Maintenance of sinus rhythm. Cardiol 2001;95:1-8.
22. Li H, Natale A, Tomassoni G, et al. Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation. Am J Cardiol 1999;84:1096-1098.
23. Capucci A, Villani GO, Aschieri D, et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 2000;21:6673.
24. Lai LP, Lin JL, Lien WP, et al. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes. Am Coll Cardiol 2000;35:1434-1441.
25. Veloso HH, de Paola AA. Sotalol pretreatment for electrical cardioversion of atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:225-226.
26. Bianconi L, Mennumi M, Luckic V, et al. Effect of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Col Cardiol 1996:28:66-73.
27. De Simone A, Stabile G, Vitale DF, et al. Pre-treatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999;34:810-814.
28. Channer KS, Birchall A, Steeds RP, et al. A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. Eur Heart J 2004;25:144-150.
29. Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067-1078.
30. Van Gelder IC, Crijns HJM, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-46.
31. Lukl J. Léčba fibrilace a fluttru síní. Interní medicína pro praxi 2001;1:8-12.
32. Abusaada K, Sharma SB, Jaladi R, et al. Epidemiology and management of new-onset atrial fibrillation. Amer J Managed Care 2004;10:S50-S57.
33. Shelton RJ, Allinson A, Johnson T, et al. Four years experience of a nurse-led elective cardioversion service within a district general hospital setting. Europace 2006;8:81-85.
34. Tse HF, Lau CP. Is there a role of cardioversion of very chronic atrial fibrillation by transvenous atrial defibrillation. J Am Coll Cardiol 1998;31:32A.
35. Balážová K, Kaliská G, Kovář F, et al. Elektrokardioverzia u pacientov s fibriláciou predsiení. Cardiol 1999;(Suppl.):7A (Abstract 3).
36. Ewy GA. The optimal technique for electrical cardioversion of atrial fibrillation. Clin Cardiol 1994;17:79-84.
37. Levy S, Ricard P, Gueunoun M. Low energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. Circulation 1997;96:253-259.